Tizona Therapeutics, Inc.
Edit

Tizona Therapeutics, Inc.

http://tizonatx.com/
Tags:BioTechCenterFinTechInformationResearchUniversity
Tizona Therapeutics, Inc., is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Founded by MPM Capital and leading scientists from Dana Farber Cancer Institute, the University of Pittsburgh, Johns Hopkins, Memorial Sloan Kettering Cancer Center, and Brigham and Women’s Hospital, Tizona’s therapies are designed to modulate the activity of immunosuppressive cells, thereby activating the body’s ability to fight cancer or preventing the immune system from attacking healthy tissues in autoimmune diseases. Our programs target the cell types and biological mechanisms responsible for immune suppression in the tumor microenvironment and for controlling self-reactivity in autoimmunity. For more information, please email info@tizonatx.com.
Location: United States, California, South San Francisco
Member count: 11-50
Total raised: $343M
Founded date: 2015

Investors 5

Funding Rounds 2

DateSeriesAmountInvestorsDeal News
21.07.2020-$300M--
08.03.2016Series B$43M-fiercebiot...

Mentions in press and media 8

DateTitleDescriptionCategoryAuthorSource
26.08.2020Tizona com...Tizona has com­plet­ed the spi...-Max Gelman...endpts.com...
09.03.2016Tizona sig...---lightstone...
08.03.2016Tizona The...---mpmcapital...
08.03.2016Tizona The...Tizona Therapeutics, Inc., a S...USA-finsmes.co...
08.03.2016 Amgen ...Thousand Oaks-based Amgen has ...--socaltech....
08.03.2016Tizona The...Proceeds will be Used to Advan...Venture Ca...-fiercebiot...
08.03.2016TIZONA THE...---lightstone...
08.03.2016Tizona The... SAN FRANCISCO, CA, Tizona Th...--vcnewsdail...